188 related articles for article (PubMed ID: 24763873)
1. Effects of fasudil on hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats.
Sun XZ; Tian XY; Wang DW; Li J
Eur Rev Med Pharmacol Sci; 2014; 18(7):959-64. PubMed ID: 24763873
[TBL] [Abstract][Full Text] [Related]
2. Targeting the RhoA-ROCK pathway to regulate T-cell homeostasis in hypoxia-induced pulmonary arterial hypertension.
Li C; Liu PP; Tang DD; Song R; Zhang YQ; Lei S; Wu SJ
Pulm Pharmacol Ther; 2018 Jun; 50():111-122. PubMed ID: 29673911
[TBL] [Abstract][Full Text] [Related]
3. Fasudil preserves lung endothelial function and reduces pulmonary vascular remodeling in a rat model of end‑stage pulmonary hypertension with left heart disease.
Zhuang R; Wu J; Lin F; Han L; Liang X; Meng Q; Jiang Y; Wang Z; Yue A; Gu Y; Fan H; Zhou X; Liu Z
Int J Mol Med; 2018 Sep; 42(3):1341-1352. PubMed ID: 29901088
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced pulmonary arterial hypertension augments lung injury and airway reactivity caused by ozone exposure.
Zychowski KE; Lucas SN; Sanchez B; Herbert G; Campen MJ
Toxicol Appl Pharmacol; 2016 Aug; 305():40-45. PubMed ID: 27286659
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of pulmonary hypertension secondary to left ventricular dysfunction in the rat by Rho-kinase inhibitor fasudil.
Dai ZK; Wu BN; Chen IC; Chai CY; Wu JR; Chou SH; Yeh JL; Chen IJ; Tan MS
Pediatr Pulmonol; 2011 Jan; 46(1):45-59. PubMed ID: 20717937
[TBL] [Abstract][Full Text] [Related]
6. Fasudil, a Rho‑kinase inhibitor, prevents intima‑media thickening in a partially ligated carotid artery mouse model: Effects of fasudil in flow‑induced vascular remodeling.
Zhang X; Zhang T; Gao F; Li Q; Shen C; Li Y; Li W; Zhang X
Mol Med Rep; 2015 Nov; 12(5):7317-25. PubMed ID: 26458725
[TBL] [Abstract][Full Text] [Related]
7. Effect of Rho kinase inhibitor fasudil on the expression ET-1 and NO in rats with hypoxic pulmonary hypertension.
Sun XZ; Li SY; Tian XY; Hong Z; Li JX
Clin Hemorheol Microcirc; 2019; 71(1):3-8. PubMed ID: 29660902
[TBL] [Abstract][Full Text] [Related]
8. [Effects of intervention with Rho kinase inhibitor fasudil on rats with hypoxic pulmonary hypertension].
Sun XZ; Wang DW; Li J
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):946-7. PubMed ID: 17254468
[No Abstract] [Full Text] [Related]
9. Effect of fasudil on hypoxic pulmonary hypertension and right ventricular hypertrophy in rats.
Sun XZ; Li SY; Tian XY; Wu QQ
Int J Clin Exp Pathol; 2015; 8(8):9517-21. PubMed ID: 26464714
[TBL] [Abstract][Full Text] [Related]
10. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
Li F; Xia W; Li A; Zhao C; Sun R
Pharmacol Res; 2007 Jan; 55(1):64-71. PubMed ID: 17127075
[TBL] [Abstract][Full Text] [Related]
11. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
Chen XY; Dun JN; Miao QF; Zhang YJ
Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
[TBL] [Abstract][Full Text] [Related]
12. Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice.
Abe K; Tawara S; Oi K; Hizume T; Uwatoku T; Fukumoto Y; Kaibuchi K; Shimokawa H
J Cardiovasc Pharmacol; 2006 Dec; 48(6):280-5. PubMed ID: 17204906
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.
Li FH; Xia W; Li AW; Zhao CF; Sun RP
Chin Med J (Engl); 2007 Jan; 120(1):22-9. PubMed ID: 17254483
[TBL] [Abstract][Full Text] [Related]
14. Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats.
Oka M; Homma N; Taraseviciene-Stewart L; Morris KG; Kraskauskas D; Burns N; Voelkel NF; McMurtry IF
Circ Res; 2007 Mar; 100(6):923-9. PubMed ID: 17332430
[TBL] [Abstract][Full Text] [Related]
15. Fasudil alleviated hypoxia-induced pulmonary hypertension by stabilizing the expression of angiotensin-(1-7) in rats.
Wang YX; Liu ML; Zhang B; Fu EQ; Li ZC
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(15):3304-12. PubMed ID: 27467008
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of clinical efficacy of fasudil for the treatment of pulmonary arterial hypertension.
Raja SG
Recent Pat Cardiovasc Drug Discov; 2012 Aug; 7(2):100-4. PubMed ID: 22670803
[TBL] [Abstract][Full Text] [Related]
17. Effects of rho-kinase inhibition on pulmonary hypertension, lung growth, and structure in neonatal rats chronically exposed to hypoxia.
Ziino AJ; Ivanovska J; Belcastro R; Kantores C; Xu EZ; Lau M; McNamara PJ; Tanswell AK; Jankov RP
Pediatr Res; 2010 Feb; 67(2):177-82. PubMed ID: 19858775
[TBL] [Abstract][Full Text] [Related]
18. Acute vasodilator effect of fasudil, a Rho-kinase inhibitor, in monocrotaline-induced pulmonary hypertension in rats.
Jiang BH; Tawara S; Abe K; Takaki A; Fukumoto Y; Shimokawa H
J Cardiovasc Pharmacol; 2007 Feb; 49(2):85-9. PubMed ID: 17312448
[TBL] [Abstract][Full Text] [Related]
19. Effects of combined therapy with a Rho-kinase inhibitor and prostacyclin on monocrotaline-induced pulmonary hypertension in rats.
Tawara S; Fukumoto Y; Shimokawa H
J Cardiovasc Pharmacol; 2007 Aug; 50(2):195-200. PubMed ID: 17703136
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Rho-kinase Attenuates Left Ventricular Remodeling Caused by Chronic Intermittent Hypoxia in Rats via Suppressing Myocardial Inflammation and Apoptosis.
Wang ZH; Zhu D; Xie S; Deng Y; Pan Y; Ren J; Liu HG
J Cardiovasc Pharmacol; 2017 Aug; 70(2):102-109. PubMed ID: 28437280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]